...
首页> 外文期刊>International Journal of Experimental Diabetes Research: Experimental Diabesity Research >MicroRNA-22 Promotes Renal Tubulointerstitial Fibrosis by Targeting PTEN and Suppressing Autophagy in Diabetic Nephropathy
【24h】

MicroRNA-22 Promotes Renal Tubulointerstitial Fibrosis by Targeting PTEN and Suppressing Autophagy in Diabetic Nephropathy

机译:MicroRNA-22通过靶向PTEN并抑制糖尿病性肾病中的自噬促进肾小管间质纤维化。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Renal tubulointerstitial fibrosis (TIF) is a major feature of diabetic nephropathy (DN). There is increasing evidence demonstrating that microRNAs act as key players in the regulation of autophagy and are involved in DN. However, the exact link among microRNAs, autophagy, and TIF in DN is largely unknown. In this study, our results showed that TIF was observed in DN rats together with obvious autophagy suppression. Moreover, microRNA-22 (miR-22) was upregulated and associated with reduced expression of its target gene phosphatase and tensin homolog (PTEN) in both the kidneys of DN rats and high glucose-cultured NRK-52E cells. Intriguingly, induction of autophagy by rapamycin antagonized high glucose-induced collagen IV (Col IV) and α-SMA expression. In addition, ectopic expression of miR-22 suppressed autophagic flux and induced the expression of Col IV and α-SMA, whereas the inhibition of endogenous miR-22 effectively relieved high glucose-induced autophagy suppression and the expression of Col IV and α-SMA in NRK-52E cells. Overexpression of PTEN protectively antagonized high glucose- and miR-22-induced autophagy suppression and the expression of Col IV. Therefore, our findings indicated that miR-22 may promote TIF by suppressing autophagy partially via targeting PTEN and represents a novel and promising therapeutic target for DN.
机译:肾小管间质纤维化(TIF)是糖尿病性肾病(DN)的主要特征。越来越多的证据表明,microRNA在自噬调节中起关键作用,并参与DN。但是,DN中的microRNA,自噬和TIF之间的确切联系很大程度上未知。在这项研究中,我们的结果表明,在DN大鼠中观察到TIF并具有明显的自噬抑制作用。此外,在DN大鼠的肾脏和高葡萄糖培养的NRK-52E细胞中,microRNA-22(miR-22)均被上调并与其靶基因磷酸酶和张力蛋白同源物(PTEN)的表达降低有关。有趣的是,雷帕霉素诱导的自噬可拮抗高葡萄糖诱导的胶原IV(Col IV)和α-SMA的表达。此外,miR-22的异位表达可抑制自噬通量并诱导Col IV和α-SMA的表达,而内源性miR-22的抑制可有效缓解高糖诱导的自噬抑制以及Col IV和α-SMA的表达。在NRK-52E细胞中PTEN的过表达保护性拮抗高糖和miR-22诱导的自噬抑制作用以及Col IV的表达。因此,我们的研究结果表明,miR-22可能通过靶向PTEN抑制部分自噬而促进TIF,并代表了DN的一种新的有希望的治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号